USD
CJC-1295 with DAC vs No DAC is primarily an identity and modification question. DAC means Drug Affinity Complex, a modification developed to extend association with circulating albumin. âNo DACâ is widely used in online catalogs, but researchers should not assume that every product carrying that phrase has the same sequence or documentation.
- DAC is a chemical modification, not a dose label.
- No-DAC naming is not sufficiently precise without sequence documentation.
- A CJC-1295 and ipamorelin blend contains two distinct compounds.
What changes when DAC is present?
| Field | With DAC | Catalog label âNo DACâ |
|---|---|---|
| Core description | GHRH analog with Drug Affinity Complex | GHRH-related material without that affinity tag |
| Key documentation | Sequence plus DAC modification | Exact sequence and chemical form |
| Main catalog risk | Omitting the modification | Assuming the name uniquely identifies one sequence |
The original clinical literature on CJC-1295 evaluated a long-acting DAC-modified analog and reported an estimated half-life measured in days. That result belongs to the studied material and protocol. It should not be copied onto a No-DAC listing or a blend without matching identity evidence.
Why No-DAC labels need extra scrutiny
Online sellers sometimes use âCJC-1295 No DACâ and âmodified GRF (1-29)â as if they were automatically interchangeable. Naming conventions can drift between catalogs. A defensible record therefore includes the full name, amino-acid sequence when supplied, chemical form, strength, vial count and lot documentation.
Compare the NOVABIO CD2 CJC-1295 with DAC listing with the CP10 CJC-1295 No DAC plus Ipamorelin blend. The second page is also a blend, so its total listed mass should not be treated as the mass of either component unless the component allocation is stated.
A five-field identity check
- Full catalog name and SKU
- DAC status
- Single compound or blend
- Listed mass per vial and total vial count
- Lot-specific analytical documentation, when available
Browse related entries in Growth & Signaling Research. For help decoding a title, see the NOVABIO product-name guide or ask through Contact Us.
Limitations
Identity terminology does not establish purity, biological activity, safety or regulatory status. It also does not provide a protocol. This guide is designed for catalog comparison and documentation, not for human administration or dose selection.
Frequently asked questions
What does DAC mean in CJC-1295?
DAC stands for Drug Affinity Complex. It is a chemical modification developed to bind the CJC-1295 analog to circulating albumin and extend exposure in the material studied in published research. DAC describes the modification; it does not indicate milligrams, vial count, purity or approval status.
Is CJC-1295 No DAC one exact compound?
Not reliably from the catalog phrase alone. âNo DACâ is used inconsistently across online listings and may be paired with names such as modified GRF (1-29). Researchers should verify the exact sequence, chemical form and documentation instead of assuming that two similarly titled products are identical.
How is a CJC-1295 and ipamorelin blend different?
A blend contains two separately named compounds in one listing. CJC-1295 is GHRH-related, while ipamorelin is a growth hormone secretagogue receptor agonist. The total blend mass does not reveal each componentâs amount unless the product specification explicitly gives that allocation.
Sources
- PubMed: prolonged CJC-1295 pharmacology (accessed 2026-08-27)
- PubMed: CJC-1295 and GH pulsatility (accessed 2026-08-27)
- PubMed: ipamorelin as a secretagogue (accessed 2026-08-27)
Research-use notice: This article explains catalog identity and published research. It is not medical advice, a treatment claim or a dosing guide. NOVABIO catalog products are presented for laboratory research and are not represented here as approved for human use.